Korgan, Austin C.
Foxx, Christine L.
Hashmi, Heraa
Sago, Saydie A.
Stamper, Christopher E.
Heinze, Jared D.
O’Leary, Elizabeth
King, Jillian L.
Perrot, Tara S.
Lowry, Christopher A.
Weaver, Ian C. G.
Funding for this research was provided by:
Nova Scotia Health Research Foundation (MED-SS-2014-9644)
Killam Foundation
Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-04348, RGPIN-2013-436204)
National Institute of Mental Health (1R21MH116263)
Colorado Office of Economic Development and International Trade Advanced Industries Accelerator Program (CTGG1-2020-3064)
Article History
Received: 24 July 2021
Accepted: 1 June 2022
First Online: 17 June 2022
Competing interests
: CL serves on the Scientific Advisory Board of Immodulon Therapeutics, Ltd., is cofounder and Chief Scientific Officer of Mycobacteria Therapeutics Corporation, and is a member of the Faculty of the Integrative Psychiatry Institute. The other authors declare no competing interests.